The veterans affairs high-density lipoprotein intervention trial: Baseline characteristics of normocholesterolemic men with coronary artery disease and low levels of high-density lipoprotein cholesterol (Q61785739)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 September 1996

Language	Label	Description	Also known as
English	The veterans affairs high-density lipoprotein intervention trial: Baseline characteristics of normocholesterolemic men with coronary artery disease and low levels of high-density lipoprotein cholesterol	scientific article published on 01 September 1996

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8806347%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

The Veterans Affairs High-Density Lipoprotein Intervention Trial: baseline characteristics of normocholesterolemic men with coronary artery disease and low levels of high-density lipoprotein cholesterol. Veterans Affairs Cooperative Studies Program High-Density Lipoprotein Intervention Trial Study Group (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8806347%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

1 reference

based on heuristic

inferred from title

coronary artery disease

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

H B Rubins

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8806347%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

S J Robins

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8806347%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

D Collins

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8806347%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

language of work or name

0 references

publication date

1 September 1996

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8806347%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

American Journal of Cardiology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8806347%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

78

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8806347%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8806347%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

572-575

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8806347%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

Distribution of lipids in 8,500 men with coronary artery disease. Department of Veterans Affairs HDL Intervention Trial Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900369-4

7 January 2021

Protocol for a prospective collaborative overview of all current and planned randomized trials of cholesterol treatment regimens. Cholesterol Treatment Trialists' (CTT) Collaboration

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900369-4

7 January 2021

Rationale and design of the Department of Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial (HIT) for secondary prevention of coronary artery disease in men with low high-density lipoprotein cholesterol and desirable low-densi

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900369-4

7 January 2021

The effects of fibrates on lipoprotein and hemostatic coronary risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900369-4

7 January 2021

Microtubules and beta cell function: effect of colchicine on microtubules and insulin secretion in vitro by mouse beta cells

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900369-4

7 January 2021

Rationale and design of a secondary prevention trial of increasing serum high-density lipoprotein cholesterol and reducing triglycerides in patients with clinically manifest atherosclerotic heart disease (the Bezafibrate Infarction Prevention Trial)

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900369-4

7 January 2021

Lack of association between cholesterol and coronary heart disease mortality and morbidity and all-cause mortality in persons older than 70 years

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900369-4

7 January 2021

Mortality among diabetics in a national sample

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900369-4

7 January 2021

The chronic cardiovascular risk factor syndrome (syndrome X): mechanisms and implications for atherogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900369-4

7 January 2021

Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900369-4

7 January 2021

Long-term predictors of subsequent cardiovascular events with coronary artery disease and 'desirable' levels of plasma total cholesterol

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900369-4

7 January 2021

Ten-year mortality from cardiovascular disease in relation to cholesterol level among men with and without preexisting cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900369-4

7 January 2021

Plasma triglyceride as a risk factor for coronary heart disease. The epidemiologic evidence and beyond

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900369-4

7 January 2021

Reduction of mortality in the Stockholm Ischaemic Heart Disease Secondary Prevention Study by combined treatment with clofibrate and nicotinic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900369-4

7 January 2021

Identifiers

10.1016/S0002-9149(96)00369-4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8806347%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8806347%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q61785739&oldid=2111139362"